Michelle Scott reflects on the preparation, adaptability, teamwork, and patient trust behind a first-in-human medical device trial.
After more than 30 years as a registered nurse and 16 years in clinical research, from OR bedside nursing to research coordinator, case support, project management, and Clinical Operations Manager, I have learned that no two trials are ever truly the same. Of all the studies I have supported, one experience has stayed with me: supporting a first-in-human medical device trial.
First-in-human trials carry a different kind of weight. There is no established roadmap, no long-term safety data, and often no precedent for how the device will perform once it is used in a patient. Every decision matters. Every protocol deviation is carefully reviewed. Every patient interaction feels significant because it is.
What made this experience especially meaningful was the way it brought together my nursing background and my operational responsibilities. My role required oversight of timelines, site coordination, regulatory readiness, and sponsor communication. At the same time, my nursing instincts were always present. They shaped how I approached the trial and how I supported the people involved.
The investigational device represented years of work and hope for patients with limited treatment options. By the time the study reached the clinical stage, engineers, scientists, and physicians had already invested so much into its development. But the move from concept to first patient enrollment is where the reality of clinical research feels very human.
I still remember the day of the first implantation procedure. The site had prepared carefully. We had completed training sessions, reviewed contingency plans, and checked that every regulatory and operational detail was in place. Even with all that preparation, there was tension in the room. Everyone understood the importance of the moment.
As the lead CRA and case support specialist, I found myself balancing two perspectives. I needed to help keep the study running smoothly by making sure communication was clear, documentation was accurate, and timelines stayed on track. At the same time, the nurse in me was focused on the patient: their anxiety, their trust in the study team, and the courage it takes to participate in a first-in-human trial.
One of the biggest lessons I took from that study was the importance of being adaptable. Unlike later-phase studies with more established workflows, first-in-human trials are constantly evolving. Questions come up in real time. Sites need added support. Procedures may need to be refined after the first few cases. Success depends on technical knowledge, but it also depends on teamwork, steady decision-making, and the ability to respond quickly without losing sight of patient safety.
There were moments that tested the whole team. We worked through protocol clarifications during active enrollment, managed time-sensitive communication with global stakeholders, and supported sites as they moved through the procedural learning curve. In those moments, my earlier experience as a CRA and case support specialist was invaluable. Having worked directly with sites for many years, I understood the pressure coordinators and investigators were under. That perspective helped me approach challenges with empathy, not just with a focus on metrics or deliverables.
What has stayed with me most is the resilience and commitment of the patients involved. In clinical research, we often talk about innovation, endpoints, and milestones. But behind every first-in-human study is a patient willing to place trust in something entirely new. That trust is humbling.
The trial ultimately progressed successfully. There were many operational achievements to be proud of, but the experience reinforced something I have believed throughout my career: clinical research is ultimately about people. Technology and innovation matter, but successful trials are built on relationships, communication, trust, and patient-centered care.
Looking back, supporting that first-in-human device trial was one of the defining moments of my career. It challenged me professionally, strengthened my leadership skills, and reminded me why I entered healthcare and clinical research in the first place.
Sixteen years into this industry, I still believe the most effective clinical operations leaders are the ones who never lose sight of the patient experience behind the protocol. For me, being a nurse and a clinical research professional have never felt like two separate identities. Together, they form the foundation for how I lead, support teams, and contribute to advancing medical innovation.